Clinical Trial Update: Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating a Venetoclax-containing regimen with microtransplant for patients with intermediate-risk or higher myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING